Skip to main content

Protagonist Therapeutics, Inc 10-Q for FY2025 Q1

Protagonist Therapeutics, Inc (PTGX)

10-Q 2025-05-06 For: 2025-03-31
View Original
Added on April 07, 2026

About this 10-Q

Protagonist Therapeutics, Inc filed this 10-Q on May 6, 2025, covering the quarter ended March 31, 2025 (FY2025 Q1).

Headline figures

Quarter ended March 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$28.32M
down 88.9% from $254.95M a year earlier
Net loss
$11.66M
compared with net income of $207.34M a year earlier
Diluted EPS
-$0.19
compared with $3.26 a year earlier